Ultima Genomics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 308

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 17

Ultima Genomics General Information

Description

Developer of genome-scale sequencing technology designed to offer analytical services to enterprises. The company uses an open substrate to create a massive, low-cost reaction surface that delivers many billions of reads while avoiding costly flow cells and complicated fluidics, and uses specialized sequencing hardware along with machine learning to deliver reproducible and accurate results, enabling clients to get genomics reports at scale with speed and efficiency and to drive down the costs of sequencing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4209 Technology Drive
  • Fremont, CA 94538
  • United States
+1 (650)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Laboratory Services (Healthcare)
Diagnostic Equipment
Corporate Office
  • 4209 Technology Drive
  • Fremont, CA 94538
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ultima Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC Completed Generating Revenue
7. Later Stage VC (Series E) 31-May-2022 Completed Generating Revenue
6. Later Stage VC (Series D) 22-Dec-2021 Completed Generating Revenue
5. Later Stage VC (Series C) Completed Generating Revenue
4. Grant 01-Jan-2020 Completed Generating Revenue
3. Early Stage VC (Series B) Completed Generating Revenue
2. Early Stage VC (Series A) 28-Dec-2017 $31M $43.8M Completed Generating Revenue
1. Seed Round $12.8M $12.8M Completed Generating Revenue
To view Ultima Genomics’s complete valuation and funding history, request access »

Ultima Genomics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E
Series E-1
Series D
Series C
Series B
Series A 9,759,520 $0.000100 $3.24 $3.24 1x $3.24 13.48%
Seed 7,157,895 $0.000100 $1.78 $1.78 1x $1.78 9.89%
To view Ultima Genomics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Ultima Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of genome-scale sequencing technology designed to offer analytical services to enterprises. The company uses a
Discovery Tools (Healthcare)
Fremont, CA
308 As of 2026

San Diego, CA
 

Lausanne, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ultima Genomics Competitors (22)

One of Ultima Genomics’s 22 competitors is Illumina, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Illumina Formerly VC-backed San Diego, CA
Adaptyv Venture Capital-Backed Lausanne, Switzerland
DNAe Formerly VC-backed London, United Kingdom
ATUM (Biotechnology) Formerly VC-backed Newark, CA
Diagenode Formerly VC-backed Seraing, Belgium
You’re viewing 5 of 22 competitors. Get the full list »

Ultima Genomics Patents

Ultima Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026217964-A1 Systems and methods for high throughput sequencing Pending 11-Apr-2025
WO-2026178174-A2 Adapter sequences and methods of use thereof Pending 18-Feb-2025
US-20250377524-A1 Novel illumination and background rejection for enhanced resolution imaging Pending 07-Jun-2024
WO-2025213126-A2 Systems and methods for spatial reference sequencing Pending 05-Apr-2024
WO-2025213126-A3 Systems and methods for spatial reference sequencing Pending 05-Apr-2024 C12Q1/6874
To view Ultima Genomics’s complete patent history, request access »

Ultima Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ultima Genomics Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
aMoon Fund Venture Capital Minority
Andreessen Horowitz Venture Capital Minority
Bow River Capital PE/Buyout Minority
D1 Capital Partners Hedge Fund Minority
Founders Fund Venture Capital Minority
You’re viewing 5 of 17 investors. Get the full list »

Ultima Genomics FAQs

  • When was Ultima Genomics founded?

    Ultima Genomics was founded in 2016.

  • Where is Ultima Genomics headquartered?

    Ultima Genomics is headquartered in Fremont, CA.

  • What is the size of Ultima Genomics?

    Ultima Genomics has 308 total employees.

  • What industry is Ultima Genomics in?

    Ultima Genomics’s primary industry is Discovery Tools (Healthcare).

  • Is Ultima Genomics a private or public company?

    Ultima Genomics is a Private company.

  • What is Ultima Genomics’s current revenue?

    The current revenue for Ultima Genomics is .

  • How much funding has Ultima Genomics raised over time?

    Ultima Genomics has raised $600M.

  • Who are Ultima Genomics’s investors?

    aMoon Fund, Andreessen Horowitz, Bow River Capital, D1 Capital Partners, and Founders Fund are 5 of 17 investors who have invested in Ultima Genomics.

  • Who are Ultima Genomics’s competitors?

    Illumina, Adaptyv, DNAe, ATUM (Biotechnology), and Diagenode are some of the 22 competitors of Ultima Genomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process